Scavenger receptor class B type I and immune dysfunctions

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 21, Issue 2, 2014, Pages 121-128

  Zheng, Zhong ^a   Ai, Junting ^a   Li, Xiang An ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

atherosclerosis; dysfunctions; HDL; immunity; inflammation; sepsis; SR BI

Indexed keywords

HIGH DENSITY LIPOPROTEIN RECEPTOR; SCAVENGER RECEPTOR BI;

ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; HEPATITIS C VIRUS; HUMAN; IMMUNITY; IMMUNOPATHOLOGY; INFECTION SENSITIVITY; LIPOPROTEIN METABOLISM; LYMPHOCYTE; NONHUMAN; REVIEW; SEPSIS; VIRUS ENTRY; VIRUS INFECTIVITY;

ADAPTIVE IMMUNITY; ANIMALS; ATHEROSCLEROSIS; AUTOIMMUNE DISEASES; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; HUMANS; LIPOPROTEINS, HDL; MICE; MICE, KNOCKOUT; OXIDATIVE STRESS; RECEPTORS, LIPOPROTEIN; SCAVENGER RECEPTORS, CLASS B; SEPSIS;

EID: 84896898635     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0000000000000046     Document Type: Review

References (111)

1. Krieger M. Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. J Clin Invest 2001; 108:793-797
2. Acton SL, Scherer PE, Lodish HF, Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem 1994; 269:21003-21009
3. Rigotti A, Acton SL, Krieger M. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem 1995; 270:16221-16224
4. Acton S, Rigotti A, Landschulz KT, et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271:518-520
5. Kozarsky KF, Donahee MH, Rigotti A, et al. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997; 387:414-417
6. Rigotti A, Trigatti BL, Penman M, et al. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA 1997; 94:12610-12615
7. Trigatti BL, Krieger M, Rigotti A. Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol 2003; 23:1732-1738
8. Hoekstra M, Van Berkel TJ, Van Eck M. Scavenger receptor BI: A multipurpose player in cholesterol and steroid metabolism. World J Gastroenterol 2010; 16:5916-5924
9. Out R, Hoekstra M, Spijkers JA, et al. Scavenger receptor class B type I is solely responsible for the selective uptake of cholesteryl esters from HDL by the liver and the adrenals in mice. J Lipid Res 2004; 45:2088-2095
10. Brundert M, Ewert A, Heeren J, et al. Scavenger receptor class B type I mediates the selective uptake of high-density lipoprotein-Associated cholesteryl ester by the liver in mice. Arterioscler Thromb Vasc Biol 2005; 25:143-148
11. Meyer JM, Graf GA, van Der Westhuyzen DR. New developments in selective cholesteryl ester uptake. Curr Opin Lipidol 2013; 24:386-392
12. Ji Y, Jian B, Wang N, et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 1997; 272: 20982-20985
13. Jian B, De la Llera-Moya M, Ji Y, et al. Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J Biol Chem 1998; 273:5599-5606
14. Van Eck M, Bos IS, Hildebrand RB, et al. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development. Am J Pathol 2004; 165:785-794
15. Vergeer M, Korporaal SJ, Franssen R, et al. Genetic variant of the scavenger receptor BI in humans. N Engl J Med 2011; 364:136-145
16. Rohrer L, Ohnsorg PM, Lehner M, et al. High-density lipoprotein transport through aortic endothelial cells involves scavenger receptor BI and ATPbinding cassette transporter G1. Circ Res 2009; 104:1142-1150
17. Lim HY, Thiam CH, Yeo KP, et al. Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL. Cell Metab 2013; 17:671-684
18. Martel C, Li W, Fulp B, et al. Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J Clin Invest 2013; 123:1571-1579
19. Trigatti B, Covey S, Rizvi A. Scavenger receptor class B type I in high-density lipoprotein metabolism, atherosclerosis and heart disease: Lessons from gene-Targeted mice. Biochem Soc Trans 2004; 32:116-120
20. Mineo C, Shaul PW. Functions of scavenger receptor class B, type I in atherosclerosis. Curr Opin Lipidol 2012; 23:487-493
21. Brooke AM, Kalingag LA, Miraki-Moud F, et al. Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement. Clin Endocrinol 2006; 65:673-680
22. Casson PR, Santoro N, Elkind-Hirsch K, et al. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: A six-month trial. Fertil Steril 1998; 70:107-110
23. Bhavnani BR, Cecutti A, Dey MS. Biologic effects of delta-8-estrone sulfate in postmenopausal women. J Soc Gynecol Invest 1998; 5:156-160
24. Brunham LR, Tietjen I, Bochem AE, et al. Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans. Clin Genet 2011; 79:575-581
25. Li XA, Titlow WB, Jackson BA, et al. High density lipoprotein binding to scavenger receptor, class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner. J Biol Chem 2002; 277:11058-11063
26. Yuhanna IS, Zhu Y, Cox BE, et al. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat Med 2001; 7:853-857
27. Mineo C, Yuhanna IS, Quon MJ, Shaul PW. High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. J Biol Chem 2003; 278:9142-9149
28. Gong M, Wilson M, Kelly T, et al. HDL-Associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner. J Clin Invest 2003; 111:1579-1587
29. Li XA, Guo L, Dressman JL, et al. A novel ligand-independent apoptotic pathway induced by scavenger receptor class B, type I and suppressed by endothelial nitric-oxide synthase and high density lipoprotein. J Biol Chem 2005; 280:19087-19096
30. Feng H, Guo L, Gao H, Li XA. Deficiency of calcium and magnesium induces apoptosis via scavenger receptor BI. Life Sci 2011; 88:606-612
31. Holm TM, Braun A, Trigatti BL, et al. Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI. Blood 2002; 99:1817-1824
32. Meurs I, Hoekstra M, van Wanrooij EJ, et al. HDL cholesterol levels are an important factor for determining the lifespan of erythrocytes. Exp Hematol 2005; 33:1309-1319
33. Dole VS, Matuskova J, Vasile E, et al. Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 2008; 28:1111-1116
34. Valiyaveettil M, Kar N, Ashraf MZ, et al. Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI. Blood 2008; 111:1962-1971
35. Brodde MF, Korporaal SJ, Herminghaus G, et al. Native high-density lipoproteins inhibit platelet activation via scavenger receptor BI: Role of negatively charged phospholipids. Atherosclerosis 2011; 215:374-382
36. Korporaal SJ, Meurs I, Hauer AD, et al. Deletion of the high-density lipoprotein receptor scavenger receptor BI in mice modulates thrombosis susceptibility and indirectly affects platelet function by elevation of plasma free cholesterol. Arterioscler Thromb Vasc Biol 2011; 31:34-42
37. Li XA, Guo L, Asmis R, et al. Scavenger receptor BI prevents nitric oxideinduced cytotoxicity and endotoxin-induced death. Circ Res 2006; 98:e60-e65
38. Cai L, Ji A, De Beer FC, et al. SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J Clin Invest 2008; 118:364-375
39. Guo L, Song Z, Li M, et al. Scavenger receptor BI protects against septic death through its role in Mmodulating inflammatory response. J Biol Chem 2009; 284:19826-19834
40. Feng H, Guo L, Wang D, et al. Deficiency of scavenger receptor BI leads to impaired lymphocyte homeostasis and autoimmune disorders in mice. Arterioscler Thromb Vasc Biol 2011; 31:2543-2551
41. Burlone ME, Budkowska A. Hepatitis C virus cell entry: Role of lipoproteins and cellular receptors. J Gen Virol 2009; 90:1055-1070
42. Popescu CI, Dubuisson J. Role of lipid metabolism in hepatitis C virus assembly and entry. Biol Cell 2010; 102:63-74
43. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138:S419-S420
44. Hansson GK, Robertson AK, Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol 2006; 1:297-329
45. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 2009; 27:165-197
46. Huszar D, Varban ML, Rinninger F, et al. Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1. Arterioscler Thromb Vasc Biol 2000; 20:1068-1073
47. Covey SD, Krieger M, Wang W, et al. Scavenger receptor class B type Imediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells. Arterioscler Thromb Vasc Biol 2003; 23:1589-1594
48. Van Eck M, Twisk J, Hoekstra M, et al. Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver. J Biol Chem 2003; 278:23699-23705
49. Braun A, Trigatti BL, Post MJ, et al. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 2002; 90:270-276
50. Ueda Y, Gong E, Royer L, et al. Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics. J Biol Chem 2000; 275:20368-20373
51. Kozarsky KF, Donahee MH, Glick JM, et al. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 2000; 20:721-727
52. Arai T, Wang N, Bezouevski M, et al. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J Biol Chem 1999; 274:2366-2371
53. El Bouhassani M, Gilibert S, Moreau M, et al. Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis. J Biol Chem 2011; 286:17227-17238
54. Picataggi A, Lim GF, Kent AP, et al. A coding variant in SR-BI (I179N) significantly increases atherosclerosis in mice. Mamm Genome 2013; 24:257-265
55. Huby T, Doucet C, Dachet C, et al. Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues. J Clin Invest 2006; 116:2767-2776
56. Zhang W, Yancey PG, Su YR, et al. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 2003; 108:2258-2263
57. Pei Y, Chen X, Aboutouk D, et al. SR-BI in bone marrow derived cells protects mice from diet induced coronary artery atherosclerosis and myocardial infarction. PLoS One 2013; 8:e72492
58. Zhao Y, Pennings M, Hildebrand RB, et al. Enhanced foam cell formation, atherosclerotic lesion development, and inflammation by combined deletion of ABCA1 and SR-BI in bone marrow-derived cells in LDL receptor knockout mice on western-Type diet. Circ Res 2010; 107:e20-e31
59. Yancey PG, Jerome WG, Yu H, et al. Severely altered cholesterol homeostasis in macrophages lacking apoE and SR-BI. J Lipid Res 2007; 48:1140-1149
60. Zhao Y, Pennings M, Vrins CL, et al. Hypocholesterolemia, foam cell accumulation, but no atherosclerosis in mice lacking ABC-Transporter A1 and scavenger receptor BI. Atherosclerosis 2011; 218:314-322
61. Fisher EA, Feig JE, Hewing B, et al. High-density lipoprotein function, dysfunction, and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 2012; 32:2813-2820
62. Zhu X, Parks JS. New roles of HDL in inflammation and hematopoiesis. Annu Rev Nutr 2012; 32:161-182
63. Barter PJ, Nicholls S, Rye KA, et al. Antiinflammatory properties of HDL. Circ Res 2004; 95:764-772
64. Van Eck M, Hoekstra M, Hildebrand RB, et al. Increased oxidative stress in scavenger receptor BI knockout mice with dysfunctional HDL. Arterioscler Thromb Vasc Biol 2007; 27:2413-2419
65. Aharoni S, Aviram M, Fuhrman B. Paraoxonase 1 (PON1) reduces macrophage inflammatory responses. Atherosclerosis 2013; 228:353-361
66. Seetharam D, Mineo C, Gormley AK, et al. High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res 2006; 98:63-72
67. Angus DC, van Der Poll T. Severe sepsis and septic shock. N Engl J Med 2013; 369:840-851
68. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
69. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554
70. Riedemann NC, Guo RF, Ward PA. The enigma of sepsis. J Clin Invest 2003; 112:460-467
71. Korhonen R, Lahti A, Kankaanranta H, Moilanen E. Nitric oxide production and signaling in inflammation. Current drug targets. Inflamm Allergy 2005; 4:471-479
72. Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: A systematic review. JAMA 2009; 301:2362-2375
73. Temel RE, Trigatti B, DeMattos RB, et al. Scavenger receptor class B, type I (SR-BI) is the major route for the delivery of high density lipoprotein cholesterol to the steroidogenic pathway in cultured mouse adrenocortical cells. Proc Natl Acad Sci USA 1997; 94:13600-13605
74. Hoekstra M, Meurs I, Koenders M, et al. Absence of HDL cholesteryl ester uptake in mice via SR-BI impairs an adequate adrenal glucocorticoidmediated stress response to fasting. J Lipid Res 2008; 49:738-745
75. Hoekstra M, van Der Sluis RJ, Van Eck M, Van Berkel TJ. Adrenal-specific scavenger receptor BI deficiency induces glucocorticoid insufficiency and lowers plasma very-low-density and low-density lipoprotein levels in mice. Arterioscler Thromb Vasc Biol 2013; 33:e39-e46
76. Han A, Marandici A, Monder C. Metabolism of corticosterone in the mouse. Identification of 11 beta, 20 alpha-dihydroxy-3-oxo-4-pregnen-21-oic acid as a major metabolite. J Biol Chem 1983; 258:13703-13707
77. Raubenheimer PJ, Young EA, Andrew R, Seckl JR. The role of corticosterone in human hypothalamic-pituitary-Adrenal axis feedback. Clin Endocrinol 2006; 65:22-26
78. Cai L, Wang Z, Ji A, et al. Macrophage SR-BI regulates pro-inflammatory signaling in mice and isolated macrophages. J Lipid Res 2012; 53:1472-1481
79. Greaves DR, Gordon S. The macrophage scavenger receptor at 30 years of age: Current knowledge and future challenges. J Lipid Res 2009; 50 (Suppl.):S282-S286
80. Stephen SL, Freestone K, Dunn S, et al. Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease. Int J Hypertens 2010; 2010:646929
81. Canton J, Neculai D, Grinstein S. Scavenger receptors in homeostasis and immunity. Nat Rev Immunol 2013; 13:621-634
82. Areschoug T, Gordon S. Scavenger receptors: Role in innate immunity and microbial pathogenesis. Cell Microbiol 2009; 11:1160-1169
83. Vishnyakova TG, Bocharov AV, Baranova IN, et al. Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1. J Biol Chem 2003; 278:22771-22780
84. Vishnyakova TG, Kurlander R, Bocharov AV, et al. CLA-1 and its splicing variant CLA-2 mediate bacterial adhesion and cytosolic bacterial invasion in mammalian cells. Proc Natl Acad Sci USA 2006; 103:16888-16893
85. Leelahavanichkul A, Bocharov AV, Kurlander R, et al. Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in mice. J Immunol 2012; 188:2749-2758
86. Guo L, Zheng Z, Ai J, et al. Comment on 'Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in mice'. J Immunol 2012; 189:501; author reply 502
87. Rigotti A, Edelman ER, Seifert P, et al. Regulation by adrenocorticotropic hormone of the in vivo expression of scavenger receptor class B type I (SR-BI), a high density lipoprotein receptor, in steroidogenic cells of the murine adrenal gland. J Biol Chem 1996; 271:33545-33549
88. Sorci-Thomas MG, Thomas MJ. High density lipoprotein biogenesis, cholesterol efflux, and immune cell function. Arterioscler Thromb Vasc Biol 2012; 32:2561-2565
89. Wilhelm AJ, Zabalawi M, Grayson JM, et al. Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity. Arterioscler Thromb Vasc Biol 2009; 29:843-849
90. Wilhelm AJ, Zabalawi M, Owen JS, et al. Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/-mice. J Biol Chem 2010; 285:36158-36169
91. Armstrong AJ, Gebre AK, Parks JS, Hedrick CC. ATP-binding cassette transporter G1 negatively regulates thymocyte and peripheral lymphocyte proliferation. J Immunol 2010; 184:173-183
92. Bensinger SJ, Bradley MN, Joseph SB, et al. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 2008; 134:97-111
93. Brundert M, Heeren J, Bahar-Bayansar M, et al. Selective uptake of HDL cholesteryl esters and cholesterol efflux from mouse peritoneal macrophages independent of SR-BI. J Lipid Res 2006; 47:2408-2421
94. Miettinen HE, Rayburn H, Krieger M. Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient mice. J Clin Invest 2001; 108:1717-1722
95. Yesilaltay A, Morales MG, Amigo L, et al. Effects of hepatic expression of the high-density lipoprotein receptor SR-BI on lipoprotein metabolism and female fertility. Endocrinology 2006; 147:1577-1588
96. Bartosch B, Vitelli A, Granier C, et al. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem 2003; 278:41624-41630
97. Zeisel MB, Koutsoudakis G, Schnober EK, et al. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology 2007; 46:1722-1731
98. Catanese MT, Graziani R, von Hahn T, et al. High-Avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein. J Virol 2007; 81:8063-8071
99. Grove J, Huby T, Stamataki Z, et al. Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. J Virol 2007; 81:3162-3169
100. Lavillette D, Tarr AW, Voisset C, et al. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 2005; 41:265-274
101. Dorner M, Horwitz JA, Robbins JB, et al. A genetically humanized mouse model for hepatitis C virus infection. Nature 2011; 474:208-211
102. Lacek K, Vercauteren K, Grzyb K, et al. Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice. J Hepatol 2012; 57:17-23
103. Meuleman P, Catanese MT, Verhoye L, et al. A human monoclonal antibody targeting scavenger receptor classBtype I precludes hepatitisCvirus infection and viral spread in vitro and in vivo. Hepatology 2012; 55:364-372
104. Rice CM. New insights into HCV replication: Potential antiviral targets. Top Antivir Med 2011; 19:117-120
105. Scarselli E, Ansuini H, Cerino R, et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 2002; 21:5017-5025
106. Maillard P, Huby T, Andreo U, et al. The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins. FASEB J 2006; 20:735-737
107. Catanese MT, Ansuini H, Graziani R, et al. Role of scavenger receptor class B type I in hepatitis C virus entry: Kinetics and molecular determinants. J Virol 2010; 84:34-43
108. Dreux M, Pietschmann T, Granier C, et al. High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI. J Biol Chem 2006; 281:18285-18295
109. Voisset C, Callens N, Blanchard E, et al. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J Biol Chem 2005; 280:7793-7799
110. Von Hahn T, Lindenbach BD, Boullier A, et al. Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells. Hepatology 2006; 43:932-942
111. Barth H, Schnober EK, Neumann-Haefelin C, et al. Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells. J Virol 2008; 82:3466-3479